Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

A Durability Index for Atopic Dermatitis: Indirect Comparison of Lebrikizumab, Dupilumab, and Tralokinumab in Maintaining Efficacy Under Variable Treatment Adherence

Saved in:
Bibliographic Details
Published in:Dermatology and Therapy
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868553983261409280
collection WordPress RSS
FRELIP Feed Integration
container_title Dermatology and Therapy
description
discipline_display Dermatology and Venereology
discipline_facet Dermatology and Venereology
format Online Article
RSS Article
genre Journal Article
id rss_article:92933
institution FRELIP
journal_source_facet Dermatology and Therapy
last_indexed 2026-06-20T21:45:41.950Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle A Durability Index for Atopic Dermatitis: Indirect Comparison of Lebrikizumab, Dupilumab, and Tralokinumab in Maintaining Efficacy Under Variable Treatment Adherence
Dermatology and Venereology
General
Dermatology and Venereology
sub_discipline_display General
sub_discipline_facet General
subject_display Dermatology and Venereology
General
Dermatology and Venereology
subject_facet Dermatology and Venereology
General
Dermatology and Venereology
title A Durability Index for Atopic Dermatitis: Indirect Comparison of Lebrikizumab, Dupilumab, and Tralokinumab in Maintaining Efficacy Under Variable Treatment Adherence
title_alt Un índice de durabilidad para dermatitis atópica: comparación indirecta de lebrikizumab, dupilumab y tralokinumab en el mantenimiento de la eficacia bajo adherencia variable al tratamiento
Un indice de durabilité pour la dermatite atopique : comparaison indirecte du lebrikizumab, du dupilumab et du tralokinumab dans le maintien de l'efficacité sous observance variable du traitement
Um Índice de Durabilidade para Dermatite Atópica: Comparação Indireta de Lebrikizumabe, Dupilumabe e Tralocinumabe na Manutenção da Eficácia sob Adesão Variável ao Tratamento
title_auth A Durability Index for Atopic Dermatitis: Indirect Comparison of Lebrikizumab, Dupilumab, and Tralokinumab in Maintaining Efficacy Under Variable Treatment Adherence
title_es_txt Un índice de durabilidad para dermatitis atópica: comparación indirecta de lebrikizumab, dupilumab y tralokinumab en el mantenimiento de la eficacia bajo adherencia variable al tratamiento
title_fr_txt Un indice de durabilité pour la dermatite atopique : comparaison indirecte du lebrikizumab, du dupilumab et du tralokinumab dans le maintien de l'efficacité sous observance variable du traitement
title_full A Durability Index for Atopic Dermatitis: Indirect Comparison of Lebrikizumab, Dupilumab, and Tralokinumab in Maintaining Efficacy Under Variable Treatment Adherence
title_fullStr A Durability Index for Atopic Dermatitis: Indirect Comparison of Lebrikizumab, Dupilumab, and Tralokinumab in Maintaining Efficacy Under Variable Treatment Adherence
title_full_unstemmed A Durability Index for Atopic Dermatitis: Indirect Comparison of Lebrikizumab, Dupilumab, and Tralokinumab in Maintaining Efficacy Under Variable Treatment Adherence
title_pt_txt Um Índice de Durabilidade para Dermatite Atópica: Comparação Indireta de Lebrikizumabe, Dupilumabe e Tralocinumabe na Manutenção da Eficácia sob Adesão Variável ao Tratamento
title_short A Durability Index for Atopic Dermatitis: Indirect Comparison of Lebrikizumab, Dupilumab, and Tralokinumab in Maintaining Efficacy Under Variable Treatment Adherence
title_sort a durability index for atopic dermatitis: indirect comparison of lebrikizumab, dupilumab, and tralokinumab in maintaining efficacy under variable treatment adherence
topic Dermatology and Venereology
General
Dermatology and Venereology
url https://link.springer.com/article/10.1007/s13555-026-01791-1